REVIEW article
Front. Immunol.
Sec. Microbial Immunology
This article is part of the Research TopicInnovative Immunological Strategies for Overcoming Antimicrobial Resistance and Enhancing Vaccine DevelopmentView all 9 articles
Pathogen-Induced Hijacking of Host SUMOylation: From Molecular Mechanisms and Prospects for Therapeutic Modulation
Provisionally accepted
- 1Amrita Vishwa Vidyapeetham Amrita School of Biotechnology, Coimbatore, India
- 2Amrita Vishwa Vidyapeetham (Amritapuri Campus), Kollam, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Post-translational modifications (PTMs) serve as essential regulatory mechanisms that fine-tune protein function, stability, localization, and interaction networks, enabling cells to adapt rapidly to physiological and pathological cues. Among the diverse PTMs, SUMOylation—the covalent attachment of Small Ubiquitin-like Modifier (SUMO) proteins to specific lysine residues on target substrates—has emerged as a dynamic and reversible modification with far-reaching implications in cellular homeostasis. Beyond its well-established roles in transcriptional regulation, DNA repair, and stress responses, recent studies highlight how pathogens have evolved to hijack the host SUMOylation machinery to subvert immune signalling, dampen inflammatory responses, and enhance intracellular survival. This review delves into the multifaceted role of SUMOylation in infectious disease, emphasizing its interplay with key host signalling cascades/axes such as NF-κB, MAPK, JAK-STAT, and interferon pathways. We explore how bacterial, viral, and fungal pathogens manipulate SUMOylation to reprogram host chromatin, modulate vesicular trafficking, and evade cytokine-mediated defences. Additionally, we examine the crosstalk between SUMOylation and other PTMs—such as ubiquitination, phosphorylation, and acetylation—that collectively shape the host-pathogen interface. By synthesizing current evidence on pathogen-driven SUMO modulation, we offer an integrated view of how this modification governs immune outcomes. Lastly, we evaluate emerging therapeutic strategies aimed at targeting SUMOylation pathways through small molecule inhibitors and genetic tools, with the goal of restoring immune competence and mitigating persistent infections. These insights position SUMOylation as a critical regulatory node and a promising target for host-directed therapies against infectious diseases.
Keywords: post-translational modifications, Sumoylation, host-pathogen interaction, therapeutic strategies, Small ubiquitin-like modifier (SUMO) proteins
Received: 16 Aug 2025; Accepted: 10 Nov 2025.
Copyright: © 2025 P, Kumar, Madhavan and Nair. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Geetha Kumar, gkumar@am.amrita.edu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.